Veracyte reported $-9647000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US $ -49.24M 1.37M
Anika Therapeutics ANIK:US $ -3.28M 0.42M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Biocept BIOC:US $ -2.77M 0.08M
Exact Sciences EXAS:US $ -167.81M 15.14M
Immunogen IMGN:US $ -62.02M 37.88M
Intrexon XON:US $ -26.15M 6.84M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Siemens SIE:GR € 1751M 696M
Veracyte VCYT:US $ -9.65M 4.82M